Dr. Jeremie Calais, assistant professor of nuclear medicine and theranostics in the department of molecular and medical pharmacology at the David Geffen School of Medicine at UCLA, is one of 26 researchers to be named a 2020 Young Investigator by the Prostate Cancer Foundation.
In a burst of jubilance at UCLA Health – an emotional release after months of pandemic trauma – frontline health care workers began receiving the Pfizer COVID-19 vaccinations on Wednesday
Researchers have identified a family of enzymes whose inhibition both protects neurons and encourages their growth, a pathway to potential new treatments for neurodegenerative diseases from Alzheimer’s to glaucoma.
Bernard Thurman was referred to a personalized cancer therapy trial at Moores Cancer Center at UC San Diego Health, a collaboration with the La Jolla Institute for Immunology, the trial employs a patient’s immune cells — specifically tumor infiltrating lymphocytes (TIL) — to destroy cancer cells.
